Identification of RASSF1A modulated genes in nasopharyngeal carcinoma.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 310, doi. 10.1038/sj.onc.1209001
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2006 AND VI 25 AND IP 2
Results: 18
1
2
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 165, doi. 10.1038/sj.onc.1209017
- By:
- Publication type:
- Article
3
The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 186, doi. 10.1038/sj.onc.1209034
- By:
- Publication type:
- Article
4
Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 248, doi. 10.1038/sj.onc.1209054
- By:
- Publication type:
- Article
5
Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 271, doi. 10.1038/sj.onc.1209018
- By:
- Publication type:
- Article
6
Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 278, doi. 10.1038/sj.onc.1209019
- By:
- Publication type:
- Article
7
High expression of shMDG1 gene is associated with low metastatic potential of tumor cells.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 317, doi. 10.1038/sj.onc.1209022
- By:
- Publication type:
- Article
8
LMP1 signaling and activation of NF-κB in LMP1 transgenic mice.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 288, doi. 10.1038/sj.onc.1209023
- By:
- Publication type:
- Article
9
β-arrestin 2 modulates the activity of nuclear receptor RAR β2 through activation of ERK2 kinase.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 218, doi. 10.1038/sj.onc.1209024
- By:
- Publication type:
- Article
10
E2F–HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 230, doi. 10.1038/sj.onc.1209025
- By:
- Publication type:
- Article
11
Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 304, doi. 10.1038/sj.onc.1209026
- By:
- Publication type:
- Article
12
Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 240, doi. 10.1038/sj.onc.1209027
- By:
- Publication type:
- Article
13
Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 298, doi. 10.1038/sj.onc.1209028
- By:
- Publication type:
- Article
14
Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 207, doi. 10.1038/sj.onc.1209029
- By:
- Publication type:
- Article
15
Src-mediated phosphorylation regulates subcellular distribution and activity of human inducible nitric oxide synthase.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 198, doi. 10.1038/sj.onc.1209030
- By:
- Publication type:
- Article
16
Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 323, doi. 10.1038/sj.onc.1209033
- By:
- Publication type:
- Article
17
Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 176, doi. 10.1038/sj.onc.1209049
- By:
- Publication type:
- Article
18
Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.
- Published in:
- Oncogene, 2006, v. 25, n. 2, p. 260, doi. 10.1038/sj.onc.1209050
- By:
- Publication type:
- Article